Page breadcrumb nav

VAERS Report 2156690

Case Report Section

Détails du rapport Vaer

Âge: 45 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: ew4109


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-05-14
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

hormone headaches; abdominal cramping and soreness; fatigue; breast soreness; delayed period; inappropriate schedule of vaccine administered; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency. the reporter is the patient. regulatory number: gb-mhra-webcovid-202202120922020420-wx60s. other case identifier(s): gb-mhra-adr 26614640. a 45 year-old female patient (not pregnant) received bnt162b2 (bnt162b2), administration date 14may2021 (lot number: ew4109) at the age of 45 years as dose 2, single for covid-19 immunisation. relevant medical history included: "asthma" (unspecified if ongoing); "ibs" (unspecified if ongoing). concomitant medication(s) included: mirena. past drug history included: sumatriptan for guttate psoriasis; salbutamol for asthma; sumatriptan for migraines. vaccination history included: bnt162b2 (dose 1), administration date: 26feb2021, for covid-19 immunisation. the following information was reported: breast pain (medically significant), outcome "not recovered", described as "breast soreness"; menstruation delayed (medically significant) with onset 14may2021, outcome "recovering", described as "delayed period"; headache (medically significant), outcome "unknown", described as "hormone headaches"; abdominal pain (medically significant), outcome "unknown", described as "abdominal cramping and soreness"; fatigue (medically significant), outcome "unknown", described as "fatigue"; inappropriate schedule of product administration (non-serious) with onset 14may2021, outcome "unknown", described as "inappropriate schedule of vaccine administered". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (13aug2020) negative. clinical course: patient has not had symptoms associated with covid-19. patient is not pregnant. patient is not currently breastfeeding. last menstrual period date was on 07feb2022. it was reported that after 2nd and booster doses, disruption to menstrual cycle in terms of timing (delay/short duration/intermittent duration). also, quite marked pms symptoms (breast soreness/hormone headaches/abdominal cramping & soreness/fatigue). patient mentioned practice nurse at smear test appointment. patient has not tested positive for covid-19 since having the vaccine. patient is not enrolled in clinical trial. no follow-up attempts are possible. no further information is expected.; sender's comments: linked report(s) : gb-pfizer inc-202200313910 same patient and product, different dose and event

Données de laboratoire
test date: 20200813; test name: covid-19 virus test; test result: negative
Liste des symptômes
fatigue headache abdominal pain breast pain inappropriate schedule of product administration sars-cov-2 test menstruation delayed
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na